Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
Le Zhang,1,2,* Fangfang Chen,2,* Shikai Geng,2,* Xiaodong Wang,2 Liyang Gu,2 Yitian Lang,1 Ting Li,2 Shuang Ye2 1Department of Pharmacy, Ren Ji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; 2Department of Rheumatology, Ren Ji Hospital, Sha...
Guardado en:
Autores principales: | Zhang L, Chen F, Geng S, Wang X, Gu L, Lang Y, Li T, Ye S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/11127d7c1f3147f9a2d41825654e3df0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
por: Ivan Padjen, et al.
Publicado: (2020) -
Structural Deformation of MTX Induced by Nanodrug Conjugation Dictate Intracellular Drug Transport and Drug Efficacy
por: Park JY, et al.
Publicado: (2021) -
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
por: Almalag H, et al.
Publicado: (2020) -
Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment
por: Karel Hloch, et al.
Publicado: (2021) -
Hydroxychloroquine for treatment of rheumatoid arthritis: multifocal electroretinogram and laser flare-cell photometry study
por: Sebastiani S, et al.
Publicado: (2017)